Dexcom expands AID partnership with Omnipod® 5 in the Netherlands, offering a tubeless HCL system for type 1 diabetes management.
Dexcom expands its Automated Insulin Delivery (AID) partnership into the Netherlands, enabling people with type 1 diabetes to use a new tubeless Hybrid Closed Loop (HCL) system, the Omnipod® 5 integrated with the Dexcom G6 Continuous Glucose Monitor (CGM) for easier diabetes management. The Omnipod® 5, the first FDA-cleared tubeless automated insulin delivery system, features mobile app control, waterproof design, and provides proactive insulin dosing to correct highs and protect against lows. The system is now available in the U.S., France, the UK, and the Netherlands.
June 20, 2024
6 Articles